Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).
about
Hamartomatous polyposis syndromes: a reviewNonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas in patients with previous adenomas and/or genetic dispositionNonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing recurrence and metachronous colorectal carcinomas in patients previously treated for colorectal cancerNonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas in general populationHistological inflammation increases the risk of colorectal neoplasia in ulcerative colitis: a systematic reviewLight and sound - emerging imaging techniques for inflammatory bowel disease.Optimal Colonoscopy Surveillance Interval after PolypectomyUse of biologics and chemotherapy in patients with inflammatory bowel diseases and cancerStatus of colitis-associated cancer in ulcerative colitisMolecular alterations in gastric cancer with special reference to the early-onset subtypeElderly patients and inflammatory bowel diseaseAdvanced gastrointestinal endoscopic imaging for inflammatory bowel diseasesCurrent status of familial gastrointestinal polyposis syndromesFrom the surface to the single cell: Novel endoscopic approaches in inflammatory bowel diseaseCrohn's disease: a clinical updateColon Capsule Endoscopy for the Detection of Colorectal Polyps: An Evidence-Based AnalysisDuodenal adenoma surveillance in patients with familial adenomatous polyposisUlcerative colitis-associated colorectal cancerIntestinal cancer in inflammatory bowel disease: natural history and surveillance guidelinesSerrated lesions of the colorectum: review and recommendations from an expert panelAdvanced endoscopic imaging for surveillance for dysplasia and colorectal cancer in inflammatory bowel disease: could the pathologist be further helped?Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitisPathogenesis of primary sclerosing cholangitis and advances in diagnosis and managementWho Needs Follow-Up after Endoscopic Resection of Colorectal Adenomas?Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitisDetection of colorectal dysplasia using fluorescently labelled lectins.Indications and surgical options for small bowel, large bowel and perianal Crohn's diseaseColorectal cancer risk in hamartomatous polyposis syndromesRisk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional StudyThe Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment.Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.Population-based screening for cancer: hope and hype.Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes.Colonic crohn disease.Radiation risks associated with serial imaging in colorectal cancer patients: should we worry?Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data.Incidence trend of malignant polyps through the data of a specialized colorectal cancer registry: clinical features and effect of screening.Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm.Estimating the Effect of Targeted Screening Strategies: An Application to Colonoscopy and Colorectal Cancer.
P2860
Q21202845-EAA600B3-B577-42EE-A6C5-4C3A7ABDA930Q24201878-3661A8FA-F7AA-46C5-9135-94C29290DB22Q24201901-846F6C70-1657-443C-BABC-65B7F3B194C2Q24202613-68517582-3F0C-420D-BAF2-92CADC911D9DQ26739021-B4ADB6D6-9874-499A-A96C-CF2B779A68F2Q26739059-A3388391-0F44-453D-A5ED-B455DEE9122CQ26739924-8B010262-A4D9-4149-A354-E31333DA2287Q26750190-21203802-7228-4CFA-9AB4-E73EB6720FEEQ26751745-1D04CCDF-24F4-45A3-8440-45C194DFA17EQ26764919-EB7C05BE-6B96-4C6A-82A2-A78147AAEB71Q26768270-1E41F33D-8DB8-4ECE-9004-F3077727E72AQ26774485-A1966EB9-C32E-46FD-95D5-C74E5C7E0DFCQ26776181-AE4C244D-7253-438F-B83F-85A2748843CDQ26777552-328931DB-6B34-43B5-B1C7-1C03DB998923Q26777696-73D68BF5-797F-4155-B49D-7E594EFFC35AQ26781084-32508CF8-7A15-4E76-88EE-B2E2462C3C52Q26799039-C0F89878-607A-4E69-A804-9AC637044895Q26822499-329A8EB1-A2C3-42AC-95DC-A95DA197EDDEQ26826827-EC1CF114-12F8-4B4C-86DF-968FC8A1745EQ26827208-3A803D5E-33FB-47B3-92AC-36CBF399D29FQ26865465-85ED85CC-E2AA-4078-A6CF-E1EDA21F607FQ27011853-F6B4FC5A-9F90-4DDC-867A-6983B4A129B5Q27015831-BFA78B24-0602-4ECF-BC9F-2456C8536AE8Q27023519-27683698-6277-4851-9D5D-9DFB0300ABADQ27314859-1E4D6108-8427-4403-ACEF-EF92F72E24D9Q27322613-254052C7-BD9A-4F39-9B13-9E62F736B2FEQ28079926-4B68E6DD-05C4-4DC0-921C-3BFC6D5D4839Q28082393-66332DF0-85E7-4FD4-A844-3BF80D28C250Q28551754-92F31C59-DA6B-4568-847F-4E20F4179CD7Q30234889-61BE30DF-BF3E-4B58-BABF-AE7FD29F47D0Q30245054-87B595CC-844A-428E-9E68-8D3EC1A00B10Q30249746-DEB14CB0-E92F-47A4-8665-B5F36FED4EC2Q30251601-39E9F453-E7A6-46E9-B524-4F7169003F1AQ30379025-C28ED840-7210-42B2-A91C-28C182ED82F6Q30412735-AC439175-A77D-4758-AA62-221C0ED169C1Q30444573-2ABB1A32-154E-4147-A7E4-22E4DFD3AA30Q30651444-6A0A6787-D118-422F-A205-B7F1F2749EE9Q30670490-DB9611CD-0CB9-4891-8EB2-8583A0FEA29DQ30851834-C3EBA19A-9C8E-4C2B-AFC6-F241EC5B4724Q30854346-56EA4DD0-5964-4F57-879C-03A1963F4CE7
P2860
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Guidelines for colorectal canc ...... isk groups (update from 2002).
@en
Guidelines for colorectal canc ...... moderate and high risk groups
@nl
type
label
Guidelines for colorectal canc ...... isk groups (update from 2002).
@en
Guidelines for colorectal canc ...... moderate and high risk groups
@nl
prefLabel
Guidelines for colorectal canc ...... isk groups (update from 2002).
@en
Guidelines for colorectal canc ...... moderate and high risk groups
@nl
P2093
P50
P356
P1433
P1476
Guidelines for colorectal canc ...... risk groups (update from 2002)
@en
P2093
Anneke Lucassen
Association of Coloproctology for Great Britain and Ireland
Brian P Saunders
British Society of Gastroenterology
Christopher R J Woodhouse
Huw J W Thomas
Jayne A Eaden
John H Scholefield
Matthew D Rutter
Paul Jenkins
P304
P356
10.1136/GUT.2009.179804
P407
P577
2010-05-01T00:00:00Z